Clinical Trials & Drug Development Specialists in Boston, MA
54 verified specialists treating clinical trials & drug development are listed for Boston, Massachusetts. Profiles cover focus areas including Genitourinary Oncology, Medical Oncology, and Head & Neck Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Newton-wellesley Hospital.
Ursula Matulonis, MD
Professor of Medicine, Harvard Medical School; Chief and Director, Division of Gynecologic Oncology, Dana-Farber Cancer Institute
Oncology
Robert Haddad, MD
Chief, Division of Head and Neck Oncology; McGraw Chair in Head and Neck Oncology; Professor of Medicine, Harvard Medical School
Oncology
Patrick Ott, MD
Professor of Medicine, Harvard Medical School; Clinical Director, Melanoma Disease Center; Director, Clinical Sciences, Center for Immuno-Oncology; Senior Physician
Oncology
Mary-Ellen Taplin, MD
Professor of Medicine, Harvard Medical School; Institute Physician and Director of Clinical Research, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Oncology
Suzanne George, MD
Chief, Division of Sarcoma; Clinical Research Director, Sarcoma Center; Associate Professor of Medicine, Harvard Medical School
Oncology
Joseph Antin, MD
Chairman of the Steering Committee of the BMT Clinical Trial Network.; Chief, Stem Cell Transplantation, Emeritus
Oncology
Geoffrey Shapiro, MD PHD
Senior Vice President, Developmental Therapeutics; Clinical Director, Center for DNA Damage and Repair; Professor of Medicine, Harvard Medical School; Institute Physician, Dana-Farber Cancer Institute
Oncology
Matthew Smith, MD PHD
Professor of Medicine, Harvard Medical School; Director, Genitourinary Oncology Program, Massachusetts General Hospital Cancer Center
Oncology
David Reardon, MD
Clinical Director, Center for Neuro-Oncology
Hematology
Erica Mayer, MD MPH
Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School; Director, Breast Cancer Clinical Research, Dana-Farber Breast Oncology Program
Oncology
Elisabeth Battinelli, M.D.
Associate Professor of Medicine, Harvard Medical School; Chief Resident, Medicine
Oncology
Elizabeth Buchbinder, M.D.
Assistant Professor of Medicine, Harvard Medical School
Oncology
Rajesh Gandhi, MD
Professor of Medicine, Harvard Medical School; Director of HIV Clinical Services and Education, Massachusetts General Hospital; Distinguished Physician, Infectious Disease
Infectious Disease
Filipa Lynce, M.D.
Assistant Professor of Medicine, Harvard Medical School; Associate Director, Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute
Oncology
George Demetri, MD
Professor of Medicine, Harvard Medical School; Director, Sarcoma Center, Dana-Farber Cancer Institute; Senior Vice President for Experimental Therapeutics, Dana-Farber Cancer Institute; Co-Director, Ludwig Center at Dana-Farber/Harvard
Oncology
Ole-Petter Hamnvik, M.D.
Assistant Professor of Medicine, Harvard Medical School
Oncology
Peter Enzinger, MD
Director, Center for Esophageal and Gastric Cancer; Associate Professor of Medicine, Harvard Medical School; Institute Physician
Oncology
Lori Wirth, MD
Elizabeth and Michael Ruane Endowed Chair of Medical Oncology; Medical Director, Center for Head and Neck Cancers; Associate Professor of Medicine, Harvard Medical School
Oncology
Jeffrey Clark, MD
Associate Professor, Medicine, Harvard Medical School
Oncology
Lecia Sequist, MD
Associate Professor of Medicine, Harvard Medical School; Mary B. Saltonstall Endowed Chair in Oncology, Massachusetts General Hospital Cancer Center
Oncology